Active Biomarkers

What do all  innovative therapies under development have in common?  Whether in preclinical or clinical stage, they all need robust and reliable biomarker assays, sound PK-PD methods and frequently immunogenicity assessments. Active Biomarkers is an integrated laboratory bringing decades of experience in the development, validation, and implementation of analytical methods. Its know-how is recognized in 4 major therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. Beyond its state-of-the-art flow cytometry and ELISpot capabilities, Active Biomarkers offers the broadest panel of immunoassay technologies ranging from standard ELISA to multiplexed methods such as Luminex, SP-X, Gyros or ELLA systems, and ultra-sensitive technologies such as MSD or Simoa. Learn more here: